» Articles » PMID: 14991571

Identification of Interleukin-8 As Estrogen Receptor-regulated Factor Involved in Breast Cancer Invasion and Angiogenesis by Protein Arrays

Overview
Journal Int J Cancer
Specialty Oncology
Date 2004 Mar 3
PMID 14991571
Citations 83
Authors
Affiliations
Soon will be listed here.
Abstract

With the goal of identifying key factors involved in human breast cancer progression, we applied human cytokine antibody arrays we have developed to screen cytokine expression levels in human breast cancer cell lines and identified interleukin (IL)-8 as a key factor involved in breast cancer invasion and angiogenesis. Elevated expression of IL-8 in breast cancer cells was associated with breast cancer invasiveness and angiogenesis. Neutralization of antibody against IL-8 specifically blocked IL-8-mediated tumor cell invasion and angiogenesis. Furthermore, IL-8 levels in human breast cancer cells were closely related to estrogen receptor (ER) status. ER positive cells expressed low levels of IL-8 whereas ER negative cells expressed high levels of IL-8. Expression of exogenous ERalpha substantially inhibited IL-8 expression. Our findings raise intriguing questions regarding the role of IL-8 in the development and progression of human breast cancer in association with ER status.

Citing Articles

Correlation Between Periodontal Disease and Oral, Oropharyngeal, and Parapharyngeal Cancers.

Daily Z, Mohammed N, Mohammed S, Hussein H Clin Cosmet Investig Dent. 2025; 17:147-158.

PMID: 40027983 PMC: 11869753. DOI: 10.2147/CCIDE.S512557.


The Role of Salivary Vascular Endothelial Growth Factor A, Cytokines, and Amino Acids in Immunomodulation and Angiogenesis in Breast Cancer.

Sarf E, Dyachenko E, Belskaya L Biomedicines. 2024; 12(6).

PMID: 38927536 PMC: 11201966. DOI: 10.3390/biomedicines12061329.


Proteomics appending a complementary dimension to precision oncotherapy.

Zhou Z, Zhang R, Zhou A, Lv J, Chen S, Zou H Comput Struct Biotechnol J. 2024; 23:1725-1739.

PMID: 38689716 PMC: 11058087. DOI: 10.1016/j.csbj.2024.04.044.


The Role of the Tumor Microenvironment in Triple-Positive Breast Cancer Progression and Therapeutic Resistance.

Pu Q, Gao H Cancers (Basel). 2023; 15(22).

PMID: 38001753 PMC: 10670777. DOI: 10.3390/cancers15225493.


3D bioprinted breast tumor-stroma models for pre-clinical drug testing.

Gonzalez-Callejo P, Vazquez-Aristizabal P, Garcia-Astrain C, Jimenez de Aberasturi D, Henriksen-Lacey M, Izeta A Mater Today Bio. 2023; 23:100826.

PMID: 37928251 PMC: 10622882. DOI: 10.1016/j.mtbio.2023.100826.